Pharma Industry News
A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.
Big pharma bosses warn Europe will miss out on lifesaving meds to China and US
Drug giants have warned Europe risks missing out on lifesaving new medicines unless governments act fast to stop investment fleeing overseas. Bosses at nine of the world's biggest pharmaceutical firms, including British giants GSK and AstraZeneca…
AbbVie vs. Eli Lilly: Which Star Pharma Stock Is a Better Buy in 2026?
Choosing between AbbVie (ABBV +0.01%) and Eli Lilly and Co (LLY +2.69%) requires weighing established income against explosive growth. Both companies lead the pharmaceutical space, but their paths for 2026 diverge significantly. AbbVie is…
Sun Pharma Launches (C)Taro-Methylphenidate ER, the First and Only Bioequivalent to Concerta with an Osmotic Delivery System
MUMBAI, India and BRAMPTON, ON, Sept. 24, 2026 /CNW/ -- Sun Pharmaceutical Industries Limited (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE: 524715, together with its subsidiaries and/or affiliated companies, 'Sun Pharma') today…
Pharma revenue growth to accelerate to 11-13% this fiscal: Crisil
Indian pharma revenue growth is expected to accelerate to 11-13 per cent this fiscal from 8 per cent last year, driven by a 14-16 per cent rise in exports as drugmakers expand beyond the US into Europe, Asia, Africa and Latin America, ratings…
Insider Selling: Royalty Pharma (NASDAQ:RPRX) EVP Sells $5,853,000.00 in Stock
Royalty Pharma PLC (NASDAQ:RPRX - Get Free Report) EVP Christopher Hite sold 100,000 shares of the stock in a transaction on Tuesday, September 22nd. The stock was sold at an average price of $58.53, for a total transaction of $5,853,000.00.
Helus Pharma Eyes Q4 Phase III Data for HLP-003 in Major Depression
Magic Mushrooms, Hard Cash: Compass Pathways' Trial Win, Fast Raise Helus Pharma, formerly known as Cybin NASDAQ: HELP, outlined its late-stage development plans for HLP-003 in adjunctive major depressive disorder (MDD) and discussed its broader…
Nuvectis Pharma (NASDAQ:NVCT) Earns 'Buy' Rating from HC Wainwright
Nuvectis Pharma (NASDAQ:NVCT - Get Free Report)'s stock had its 'buy' rating restated by equities researchers at HC Wainwright in a research note issued to investors on Thursday, Benzinga reports. They presently have a $39.00 price objective on the…
Why we like Starbucks' latest turnaround move - plus, two more wins for Eli Lilly
Every weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch — an actionable afternoon update, just in time for the last hour of trading on Wall Street. Stocks were mixed Thursday as Treasury yields surged and investors…
Strategic Transformation Supports Roquette's H1 2026 Performance
Strategic Transformation Supports Roquette's H1 2026 Performance +9% turnover growth to €2,586 million and +18% Current EBITDA increase to €337 million. Performance was supported by favorable volume and mix effects, the continued…
Fidelity Select Health Care Portfolio Q2 2026 Commentary
Outperformance was driven by superior stock selection in biotech, pharma, and health care services, with notable contributions from Oruka Therapeutics and strategic positioning in innovative assets. FSPHX is increasing exposure to innovative…
Sensex Plunges 600+ Points: Crude Oil Above $100, Global Cues Weigh on Indian Markets
Indian benchmark indices, Sensex and Nifty, witnessed a sharp decline in early trade as crude oil prices surged past $100 per barrel, coupled with weak global market trends, impacting investor sentiment. The BSE Sensex plummeted 632.68 points, and…
Eli Lilly, InnoCare Sign Deal That Could Top $3 Billion
InnoCare, a specialist in cancer and autoimmune diseases, will use its proprietary drug-discovery platform to develop new medicines with the U.S. pharma giant. Under the terms of the Thursday agreement, InnoCare will be eligible for up to $100…
Boehringer Ingelheim and WHO Foundation launch global collaboration to close the gap in obesity and metabolic health
Supporting obesity and metabolic health with a USD 5 million contribution from Boehringer Ingelheim over three years Collaboration will strengthen integrated care for obesity and related cardiovascular, kidney, liver and metabolic diseases to…
NSE enters 'top 10 most valued firms' club; shares jump 5%
Shares of National Stock Exchange of India Ltd (NSE) jumped over 5 per cent during intraday trade on Thursday after a muted debut and entered the elite club of top-10 most valued firms by market valuation. The exchange started trading at Rs 1,800…
Unscrambling Ireland's rollercoaster export figures
Ireland's exports to the US fell by 65 per cent in the first half of this year, dropping to €26.2 billion from €75.1 billion in the same period of 2025. It is the latest part of a rollercoaster ride. This scale of fall-off would…
Receive a Daily briefing on Pharma Industry News
Get Started